RecruitingNot ApplicableNCT04452305

Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting


Sponsor

University of Pittsburgh

Enrollment

10 participants

Start Date

Nov 10, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Spermatogonial stem cell transplantation through ultrasound guided rete testis injection and testicular tissue grafting will be performed for participants who have frozen testicular tissue prior to gonadotoxic therapy. The purpose of this study is to test the safety and feasibility of these transplant technologies and restore fertility for these participants.


Eligibility

Sex: MALE

Inclusion Criteria4

  • Male participant at least in Tanner stage 3
  • Previously cryopreserved and stored testicular tissue/cells (frozen due to an infertility-risking diagnosis or treatment such as chemotherapy or radiation) available for autologous transplantation and grafting
  • Healthy enough to undergo anesthesia
  • Written clearance for the procedure from the patient's hematologist or oncologist to confirm the patient has finished treatment for primary condition and are clear to undergo autologous stem cell transplant

Exclusion Criteria3

  • Participants considered to be high risk for surgical complications
  • Participants with a history of leukemia, lymphoma or testicular cancer or a cancer that likely involved testicles at the time of testicular tissue collection
  • Diagnosed with psychological, psychiatric, or other conditions which prevent giving fully informed consent.

Interventions

PROCEDURESpermatogonial Stem Cell Transplant and Testicular Tissue Grafting

Spermatogonial stem cell transplant and testicular tissue grafting is performed to produce sperm.


Locations(1)

Magee-Womens Hospital

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04452305


Related Trials